Saad Mark E
SEC CIK 1295913 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics, Inc. | Dir | 11.4K | $113.9K | $8.35M | 9 | 2021-11-17 | 2026-06-08 |
Most active insiders at AXSM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TABUTEAU HERRIOT | CEO, Dir, 10% | — | $103.22M |
| 2 | Pizzie Nick | CFO | — | $10.18M |
| 3 | Jacobson Mark L. | COO | — | $8.90M |
| 4 | Coleman Mark | Dir | — | $8.21M |
| 5 | Saad Mark E | Dir | — | $6.21M |
| 6 | Maizel Ari | Chief Commercial Off | — | $2.75M |
| 7 | Mahony Susan | Dir | — | $145.0K |
| 8 | JEFFS ROGER | Dir | — | $141.7K |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-10 21:49 | 2026-06-08 | AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Dir | M - OptEx | — | +1,429 | 11.4K | +14% | — |
| DMT | 2026-01-02 | 2025-12-31 | AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Dir | M - OptEx | $5.46 | +37.6K | 41.3K | +996% | +$205.1K |
| DMT | 2026-01-02 | 2025-12-31 | AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Dir | S - Sale+OE | $165.18 | -37.6K | 10.0K | -79% | -$6.21M |
| DT | 2025-09-05 | 2025-09-05 | AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Dir | S - Sale+OE | $125.07 | -9,127 | 10.0K | -48% | -$1.14M |
| DT | 2025-09-05 | 2025-09-05 | AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Dir | M - OptEx | $9.00 | +9,127 | 19.1K | +91% | +$82.1K |
| DT | 2024-09-11 | 2024-09-11 | AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Dir | S - Sale+OE | $91.31 | -11.0K | 10.0K | -52% | -$1.01M |
| DT | 2024-09-11 | 2024-09-11 | AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Dir | M - OptEx | $3.67 | +11.0K | 21.0K | +110% | +$40.4K |
| MI | 2021-11-19 | 2021-11-17 | AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Dir | P - Purchase | $34.42 | +300 | 100 | New | +$10.3K |
| 2021-11-19 | 2021-11-17 | AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Dir | P - Purchase | $34.53 | +3,000 | 10.0K | +43% | +$103.6K |
Purchase Sale Sale after option exercise All abbreviations